The sleep supplement market is flourishing, with an estimated $7.6 billion in revenue last year and still expanding rapidly. Among the numerous options available, a new supplement has captured significant attention, amassing a waitlist of over 28,000 individuals eagerly anticipating its release. This supplement is AGZ, developed by AG1, renowned for their Athletic Greens health drink popular among fitness enthusiasts. Unlike their morning health drink, AGZ is tailored for nighttime use, offering a unique proposition of aiding sleep without relying on melatonin.
Melatonin, a hormone naturally produced in response to darkness, plays a crucial role in signaling our bodies to prepare for sleep. While melatonin supplements can be beneficial for short-term disruptions in sleep patterns like jet lag, they may not be effective for chronic sleep issues like insomnia and could potentially disrupt the body’s natural production of the hormone over time.
AGZ contains five key ingredients aimed at promoting relaxation and improving sleep quality:
- Magnesium L-threonate: Known for its ability to cross the blood-brain barrier, this form of magnesium has been linked to enhanced sleep quality and cognitive function.
- Ashwagandha: An Ayurvedic herb, ashwagandha can reduce cortisol levels and stress, potentially aiding in relaxation before bedtime.
- Saffron: Clinical trials have demonstrated saffron’s positive impact on sleep duration and quality.
- L-theanine: Found in tea, L-theanine has shown promise in reducing sleep onset latency and improving relaxation without causing drowsiness.
- Valerian: While scientific evidence on valerian root’s efficacy is mixed, it is commonly used to alleviate anxiety, which could indirectly support better sleep.
AGZ is recommended to be consumed an hour or two before bedtime, with the flexibility to be mixed with water, milk, or non-dairy alternatives. The supplement is available in three flavors: chocolate, chocolate mint, and mixed berry, catering to various preferences.
In a saturated market dominated by celebrity-endorsed brands like Kourtney Kardashian’s and Gwyneth Paltrow’s offerings, AGZ’s ability to attract such a substantial waitlist underscores the growing demand for innovative sleep solutions. By leveraging a melatonin-free approach and incorporating scientifically backed ingredients, AGZ aims to provide a natural and effective option for those seeking improved sleep quality and relaxation.
- The sleep supplement market is valued at $7.6 billion and continues to expand rapidly.
- AGZ, a melatonin-free sleep supplement by AG1, garnered a waitlist of over 28,000 individuals.
- Melatonin supplements may not be suitable for long-term use and could disrupt natural hormone production.
- AGZ contains five key ingredients including magnesium L-threonate and ashwagandha to promote relaxation and enhance sleep quality.
- With a focus on natural ingredients and efficacy, AGZ aims to address the growing demand for innovative sleep solutions.
Tags: clinical trials
Read more on nypost.com